Paid Clinical Trials Ann Arbor

Discover 1,910 paid clinical trials in Ann Arbor, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,910

Lomustine with Temozolomide & RadiationTesting the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Ann Arbor MI, Ypsilanti MI, Canton MI, Chelsea MIshow 269 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Magnetic Resonance Imaging

Photon Beam Radiation Therapy

Questionnaire Administration

Temozolomide

AtogepantA Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

Recruiting

PHASE3

Sponsor:

AbbVie

Location:

Ann Arbor MI, London, West Chester OH, Cincinnati OHshow 35 more

Code:

NCT05711394

Conditions

Episodic Migraine

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Atogepant

Placebo-Matching Atogepant

LuspaterceptA Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

Recruiting

PHASE3

Sponsor:

Celgene

Location:

Detroit MI, Cleveland OH, Chicago IL, Torontoshow 9 more

Code:

NCT04064060

Conditions

Myelodysplastic Syndromes (MDS)

Beta-thalassemia

Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Luspatercept

ICXP007Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers

Recruiting

PHASE3

Sponsor:

Intercytex

Location:

Ann Arbor MI, London, Columbus OH, Erie PAshow 34 more

Code:

NCT00232973

Conditions

Leg Ulcer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ICXP007

AP-CD/LDA Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004

Recruiting

PHASE3

Sponsor:

Intec Pharma Ltd.

Location:

Farmington Hills MI, West Bloomfield MI, Toledo OH, East Lansing MIshow 32 more

Code:

NCT02615873

Conditions

Parkinson's Disease

Eligibility Criteria

Sex: All

Age: 30 - 70+

Healthy Volunteers: Not accepted

Interventions

Accordion Pill™ Carbidopa/Levodopa

PembrolizumabLong-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Detroit MI, Cleveland OH, London, Chicago ILshow 68 more

Code:

NCT03486873

Conditions

Solid Tumors

Hematologic Malignancies

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Standard of Care (SOC)

Lenvatinib

Olaparib

MK-4280

RavulizumabStudy of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting

PHASE3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Pontiac MI, London, Columbus OH, Milwaukee WIshow 35 more

Code:

NCT06291376

Conditions

Immunoglobulin A Nephropathy

IgAN

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ravulizumab

Placebo

NipocalimabA Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

Recruiting

PHASE2

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Ann Arbor MI, Pittsburgh PA, Hershey PA, Philadelphia PAshow 7 more

Code:

NCT05265273

Conditions

Myasthenia Gravis

Eligibility Criteria

Sex: All

Age: 2 - 17

Healthy Volunteers: Not accepted

Interventions

Nipocalimab

BI 1839100A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

Recruiting

PHASE2

Sponsor:

Boehringer Ingelheim

Location:

Warren MI, Chicago IL, Hamilton, DuBois PAshow 21 more

Code:

NCT06360094

Conditions

Idiopathic Pulmonary Fibrosis

Progressive Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BI 1839100

Placebo

RRx-001RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer

Recruiting

PHASE2

Sponsor:

EpicentRx, Inc.

Location:

Ann Arbor MI, Fort Wayne IN, Columbus OH, Chicago ILshow 10 more

Code:

NCT05966194

Conditions

Oral Mucositis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RRx-001

Intensity Modulated Radiation Therapy (IMRT)

Cisplatin for injection 100 mg/m2